veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study
NCT03544294 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2800
Last updated 2018-06-06
Summary
For permanent coronary stents, reduction of thickness of struts have become one of the most important innovation, being related to easier manipulation, reduced risk of stent thrombosis and low rate of revascularization. Consequently the investigators performed a multicenter registry enrolling all consecutive patients treated with very thin stents for ULM or bifurcation.
Conditions
- Stent Restenosis
- Stent Thrombosis
- Left Main Coronary Artery Disease
- Coronary Bifurcations
- Very Thin Stents
Interventions
- DEVICE
-
Xience alpine, ultimaster, resolute onyx, synergy
PCI will be performed
Sponsors & Collaborators
-
University Hospital, Zürich
collaborator OTHER -
A.O.U. Città della Salute e della Scienza
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2018-05-30
- Completion
- 2018-05-30
- FDA Device
- Yes
Countries
- Italy
Study Locations
More Related Trials
-
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT07190690 ·Status: RECRUITING ·Phase: NA
-
Xience Versus Synergy in Left Main PCI
NCT02303717 ·Status: UNKNOWN ·Phase: NA
-
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
NCT00233805 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
NCT05650411 ·Status: RECRUITING ·Phase: NA
-
Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries
NCT00732953 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up
NCT02384837 ·Status: COMPLETED
-
Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
NCT00232739 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent
NCT02328898 ·Status: UNKNOWN ·Phase: PHASE4
-
XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
NCT03745053 ·Status: COMPLETED ·Phase: NA
-
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
NCT01489449 ·Status: COMPLETED ·Phase: PHASE4
-
International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions
NCT01373502 ·Status: COMPLETED ·Phase: NA
-
Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent
NCT02986295 ·Status: UNKNOWN
-
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NCT05544864 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis
NCT00987324 ·Status: COMPLETED ·Phase: PHASE4
-
Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter
NCT01495533 ·Status: COMPLETED ·Phase: PHASE3
-
Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period
NCT05548023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice
NCT02853994 ·Status: UNKNOWN
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
NCT00232752 ·Status: COMPLETED ·Phase: PHASE3
-
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
NCT00916695 ·Status: UNKNOWN ·Phase: PHASE4
-
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
NCT06863155 ·Status: RECRUITING
-
In-stent Restenosis in Patients With Patent Previous Bare Metal Stent
NCT01296399 ·Status: COMPLETED
-
XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
NCT02042300 ·Status: COMPLETED
-
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
NCT00231257 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of MiStent Compared to Xience in Japan
NCT02972671 ·Status: UNKNOWN ·Phase: NA